Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
THERANEXUS : THX Pharma and Biocodex announce a strategic licensing agreement…
Biocodex has acquired two licenses from THX Pharma to develop and commercialize Batten-1 worldwide and TX01 in the United States and Canada. The total deal value is up to €173 million, including a €12 million upfront payment, up to €161 million in development and commercialization milestone payments, and tiered double-digit royalties on net sales…
Actusnews Wire
10/02/2026
Lumibird was selected by Rheinmetall for the Skyranger 30 air defence system
Lumibird was selected by Rheinmetall for the Skyranger 30 air defence system The LUMIBIRD Group (FR0000038242 – LBIRD), the European leader in laser technologies, announces that its subsidiary Lumibird Photonics Sweden AB has secured a new order from Rheinmetall Air Defence for its VIDAR laser rangefinders, to be integrated into the Skyranger 30 air defence system delivered to the Netherlands…
Actusnews Wire
09/02/2026
Oxurion Receives Transparency Notification from Atlas Special Opportunities II…
Leuven, BELGIUM – January 26, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on January 23, 2026, from Atlas Special Opportunities…
Actusnews Wire
26/01/2026
Lumibird: FY revenue of EUR 225.6 million (+10.2% at constant scope and exchange…
Lumibird: FY revenue of €225.6 million (+10.2% at constant scope and exchange rates) Growth of +10.2% at constant scope and exchange rates (+8.9% reported) Photonics Division: revenue of €113.4 million, strong growth (+15.0% at constant scope and exchange rates and +14.1% reported) confirming a clear return to growth, supported by a solid fourth…
Actusnews Wire
26/01/2026
Oxurion Receives Transparency Notification from Atlas Special Opportunities II…
Leuven, BELGIUM – January 23, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on January 22, 2026, from Atlas Special Opportunities…
Actusnews Wire
23/01/2026
Who belongs in the playground?
Industrial News Service
23/01/2026
THERANEXUS : THX Pharma Announces its 2026 Financial Calendar
Lyon, France – January 20, 2026, 18:00 p.m. CET – THX Pharma (Theranexus), an innovative biopharmaceutical company in the treatment of rare neurological diseases, today announces its financial communication agenda for. Each publication will be released after Euronext market closing, unless otherwise specified …
Actusnews Wire
20/01/2026
OXURION : Information on the Total Number of Voting Rights (Denominator)…
Atlas Special Opportunities, LLC has converted 2 convertible bonds in Oxurion resulting in a EUR 50,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment[1]. Leuven, BELGIUM – 19 januari 2026 – 06:00 PM CET – In accordance with article 15 of the Belgian Act of May 2, 2007 on the disclosure of…
Actusnews Wire
19/01/2026
DMS GROUP : EUR 50.0 MILLION IN ANNUAL REVENUE IN 2025, ORGANIC GROWTH OF +9%
Dynamic growth of +17% in activity in Q4 2025, driven by sustained international development Confirmed acceleration in growth in the 2nd half of 2025 (+14% vs. +3% in the 1st half of 2025) despite a wait-and-see market environment, particularly in France and Europe Strong development in the North American market, the main contributor to the Group's…
Actusnews Wire
19/01/2026
Oxurion kondigt de tijdelijke opschorting aan van het financieringsprogramma…
Leuven, BELGIË – 19 januari 2026 – 8u00 CET Oxurion NV (Euronext Brussel: OXUR), een farmaceutische onderaannemingsvennootschap gevestigd in Leuven, heeft het investeringsproject in digitale activa en crypto-activa, zoals op 1 december 2025 aan de markt werd meegedeeld, herbekeken. Dit project had tot doel een alternatieve activaklasse te…
Actusnews Wire
19/01/2026
Oxurion announces the temporary suspension of the financing programme dedicated…
Leuven, BELGIUM – January 19, 2026 – 08:00 AM CET - Oxurion NV (Euronext Brussels: OXUR), a pharmaceutical outsourcing company based in Leuven, has reviewed the investment project in digital assets and crypto-assets, as communicated to the market on 1 December 2025. The objective of this project was to consider an alternative asset class…
Actusnews Wire
19/01/2026
Klea Holding reports profitable growth of 34% in turnover in 2025 at constant…
Strong performance (+25% at constant currency) in the Medical Fitness segment. Revenue from the Medical Fitness segment & other services increased by a factor of 2.5. Confirmation of the target for strong EBITDA growth in 2025. First digital medical centre to open soon in Saudi Arabia. Paris, 19 January 2026 KLEA HOLDING (FR0013481835 – ALKLH), a…
Actusnews Wire
19/01/2026
Oxurion Receives Transparency Notification from Atlas Special Opportunities II…
Leuven, BELGIUM – January 13, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on January 9, 2026, from Atlas Special Opportunities II…
Actusnews Wire
13/01/2026
Evondos Group Launches in UK, delivering impressive £1.46m annualised savings in…
Industrial News Service
13/01/2026
THERANEXUS : THX Pharma announces the publication of its letter to shareholders
Lyon, France – January 8, 2025, 6:00 PM CET – THX Pharma (Theranexus), an innovative biopharmaceutical company in the treatment of rare neurological diseases, today announces the publication of its letter to shareholders. To download the newsletter, click here. This letter is also available on the Theranexus website (link), in the…
Actusnews Wire
08/01/2026
THERANEXUS : THX Pharma Announces the Appointment of Julien Veys as Deputy Chief…
Lyon, France – January 7, 2026, 8:00 a.m. CET – The Board of Directors of THX Pharma (Theranexus), a pharmaceutical company specializing in rare neurological diseases, today announces the appointment of Julien Veys as Deputy Chief Executive Officer. This appointment is part of the continued development of THX Pharma and the implementation of its…
Actusnews Wire
07/01/2026
DMS GROUP : HALF-YEAR REPORT ON THE LIQUIDITY CONTRACT ON DECEMBER 31, 2025
January 6, 2026 – 5.45 pm – Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 – ALDMS), a specialist in high-performance medical imaging systems for digital radiology and bone densitometry, communicates the half-year results of the liquidity contract entrusted by DIAGNOSTIC MEDICAL SYSTEMS to NATIXIS ODDO BHF dated May 7, 2025…
Actusnews Wire
06/01/2026
Oxurion Receives Transparency Notification from Atlas Special Opportunities II…
Leuven, BELGIUM – December 17, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on December 16, 2025, from Atlas Special Opportunities…
Actusnews Wire
17/12/2025
LEPAS L8 Exquisite Space: A Calming Emotional Sanctuary for the Emotion-Led…
For weekend escapes and spontaneous camping trips, the LEPAS L8's Exquisite Space becomes the perfect outdoor companion. The spacious trunk and flat-folding seats easily create a wide lounge area. The panoramic roof opens a clear, borderless view—no tent required—just lift your gaze to enjoy a romantic starry sky. Unfold the rear tray table and your personal mobile coffee corner comes alive. In this exquisite space, Elegant Life becomes beautifully tangible. For weekend escapes and…
PR Newswire
10/12/2025
Amyotrophic Lateral Sclerosis Market Outlook: Expanding Therapeutic Pipeline and…
Amyotrophic Lateral Sclerosis Market Summary Amyotrophic Lateral Sclerosis Market Summary Discover the amyotrophic lateral sclerosis new treatment @New Treatments for Amyotrophic Lateral Sclerosis Key Factors Driving the Growth of the Amyotrophic Lateral Sclerosis Market Rising ALS Prevalence The global incidence of ALS is on the rise, with nearly5,000new cases diagnosed annually inthe United Statesalone. The total prevalent cases of ALS in the 7MM comprised...
PR Newswire
09/12/2025
Global Skin Health Supplement Market Forecast: USD 2.57 Billion in 2025 to USD…
Beauty-from-Within Becomes the New Global Standard Beauty-from-Within Becomes the New Global Standard According to FMI, the first half of the forecast period (2025–2030) will see the market reach USD 3,463 million , adding nearly USD 896 millionin new valueas collagen-based supplements, antioxidants, and nutrient-dense formulations become essential in daily beauty and wellness routines. By 2030–2035, mass-market adoption and digital health integrations will unlock an additional ...
PR Newswire
09/12/2025
Surgical Robots Market worth $27.14 billion by 2030 | MarketsandMarkets™
Surgical Robots Market Size & Forecast: Surgical Robots Market Size & Forecast: Surgical Robots Market Trends & Insights: Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256618532 The surgical robots market is growing primarily due to the increasing demand for minimally invasive surgeries, which offer faster recovery times, reduced pain, and fewer complications. Hospitals are adopting robotic systems to enhance precision, repeatability,...
PR Newswire
09/12/2025
Immunostimulant Market to Reach $288.82 billion, Globally, by 2034 at 9.9% CAGR…
Applications span hospitals, specialty clinics, ambulatory care centers, and public health programs. With the rising burden of infectious diseases, increasing prevalence of cancer and immune-related disorders, expanding vaccination initiatives, and continuous advancements in biotechnology, the immunostimulant market is gaining strong traction globally across prophylactic and therapeutic segments. Applications span hospitals, specialty clinics, ambulatory care centers, and public health…
PR Newswire
09/12/2025
FASHIONPHILE Launches Total Investment Protection Collection, a…
The Investment Protection Collection fills a critical gap in the market by offering care products that mirror the rigorous standards used by FASHIONPHILE's own restoration experts. Developed in collaboration with FASHIONPHILE's Atelier team, the line reflects their mission to breathe new life into ultra-luxury items, one meticulous cleaning at a time. The Investment Protection Collection fills a critical gap in the market by offering care products that mirror the rigorous standards used by...
PR Newswire
09/12/2025
Altri Comunicati
